Effects of pranlukast administration on vascular endothelial growth factor levels in asthmatic patients

Chest

Volumn 125, Issue 5, 2004, Pages 1700-1705

  Kanazawa, Hiroshi ^a   Yoshikawa, Takahiro ^a   Hirata, Kazuto ^a   Yoshikawa, Junichi ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Airway microcirculation; Airway permeability; Beclomethasone dipropionate; Leukotriene antagonists

Indexed keywords

EOSINOPHIL CATIONIC PROTEIN; LEUKOTRIENE RECEPTOR BLOCKING AGENT; PRANLUKAST; STEROID; VASCULOTROPIN;

ADULT; AIRWAY; AIRWAY OBSTRUCTION; ARTICLE; ASTHMA; BLOOD VESSEL PERMEABILITY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DOUBLE BLIND PROCEDURE; DRUG EFFECT; EOSINOPHIL; FEMALE; HUMAN; LABORATORY TEST; MALE; PRIORITY JOURNAL; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; SPUTUM ANALYSIS;

EID: 2442482430     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.125.5.1700     Document Type: Article

References (19)

1. Holgate ST, Sampson AP. Antileukotriene therapy: future directions. Am J Respir Crit Care Med 2000; 161:S147-S153
2. Drazen JM. Clinical pharmacology of leukotriene receptor antagonists and 5-lipoxygenase inhibitors. Am J Respir Crit Care Med 1998; 157:S233-S237
3. Hui KP, Barnes NC. Lung function improvement in asthma with a cysteinyl-leukotriene receptor antagonist. Lancet 1991; 337:1062-1063
4. National Heart, Lung, and Blood Institute, National Institutes of Health. Global initiative for asthma. Bethesda, MD: National Institutes of Health, 1995; NIH Publication No. 95-3659
5. Pavord ID, Ward R, Woltmann G, et al. Induced sputum eicosanoid concentrations in asthma. Am J Respir Crit Care Med 1999; 160:1905-1909
6. Christian VJ, Prasse A, Naya I, et al. Zafirlukast improves asthma control in patients receiving high-dose inhaled corticosteroids. Am J Respir Crit Care Med 2000; 162: 578-585
7. Robinson DS, Campbell D, Barnes PJ. Addition of leukotriene antagonists to therapy in chronic persistent asthma: a randomised double-blind placebo controlled trial. Lancet 2001; 357:2007-2011
8. Kanazawa H, Hirata K, Yoshikawa J. Role of endogenous nitric oxide in exercise-induced airway narrowing in patients with bronchial asthma. J Allergy Clin Immunol 2000; 106: 1081-1087
9. Kanazawa H, Asai K, Hirata K, et al. Vascular involvement in exercise-induced airway narrowing in patients with bronchial asthma. Chest 2002; 122:166-170
10. Monacci WT, Merrill MJ, Oldfield EH. Expression of vascular permeability factor/vascular endothelial growth factor in normal rat tissues. Am J Physiol 1993; 264:C994-C1002
11. American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. Am Rev Respir Dis 1987; 136:225-244
12. Hele DJ, Birrell MA, Webber SE, et al. Mediator involvement in antigen-induced bronchospasm and microvascular leakage in the airways of ovalbumin sensitized Brown Norway rats. Br J Pharmacol 2001; 132:481-488
13. Asai K, Kanazawa H, Kamoi H, et al. Increased levels of vascular endothelial growth factor in induced sputum in asthmatic patients. Clin Exp Allergy 2003; 33:595-599
14. Nauck M, Roth M, Tamm M, et al. Induction of vascular endothelial growth factor by platelet-activating factor and platelet-derived growth factor is down-regulated by corticosteroids. Am J Respir Cell Mol Biol 1997; 16:398-406
15. Asai K, Kanazawa H, Otani K, et al. Imbalance between vascular endothelial growth factor and endostatin in induced sputum in asthmatics. J Allergy Clin Immunol 2002; 110:571-575
16. Esser S, Wolburg K, Wolburg H, et al. Vascular endothelial growth factor induces endothelial fenestrations in vitro. J Cell Biol 1998; 140:947-959
17. Roberts WG, Palade GE. Neovasculature induced by vascular endothelial growth factor is fenestrated. Cancer Res 1997; 57:765-772
18. Kanazawa H, Hirata K, Yoshikawa J. Involvement of vascular endothelial growth factor in exercise-induced bronchoconstriction in asthmatic patients. Thorax 2002; 57:885-888
19. Laitinen LA, Laitinen A, Widdicombe J. Effects of inflammatory and other mediators on airway vascular beds. Am Rev Respir Dis 1987; 135:567-570